TokenPost·
Appili Therapeutics Posts C$3.5 Million First-Half Net Loss
The loss widened C$1.3 million from a year earlier as the company shifted toward dual-use medical technologies and disclosed C$1.2 million in related-party advances.
More news
- TokenPostDenarius Metals Posts $8.05 Million in Q3 Revenue, $45.88 Million Loss
- TokenPostGINSMS Posts C$817,005 in Continuing-Operations Revenue Through Sept. 30, 2026
- Crypto BriefingAnthropic’s Amodei says AI coding market is maturing
- TokenPostMadison Pacific Properties Reports $0.27 in Nine-Month GAAP EPS
- Crypto BriefingTelegram founder Pavel Durov challenges hackers after security fix
- TokenPostAnthropic CEO Says Too Little Compute Risks Customers, Excess Threatens Solvency